BM
BioMark Diagnostics Inc.
BMKDF · OTC
$0.36 +0.00% (+$0.00)
1M +0.33%
Market Cap $53.3M
P/E Ratio -
Div. Yield -
ROE 250.76%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 1,915.81x
P/B 93.23x
P/E N/A
Growth
100 /100
Growing Rev. growth 51.98%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 406.91%
Net margin 5,127.10%
Op. margin 5,669.49%
Quality
0 /100
Poor ROIC 69.63%
ROE 250.76%
ROA 65.77%
Debt
13 /100
High Debt/Equity 2.64x
Current ratio 1.29x
Int. coverage -21.31x
Stability
37 /100
Moderate Beta -0.31x
Rev. volatility 143.86%
EPS volatility 23.77%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BMKDF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rashid Ahmed Maula Bux
Employees
9
Headquarters
Richmond